Algebris (Uk) LTD Genenta Science S.P.A. Put Options Transaction History

Algebris (Uk) LTD

  • $291 Million
  • Q2 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding GNTA

# of Institutions
5
Shares Held
247K
Call Options Held
0
Put Options Held
0
View Full List

About Genenta Science S.p.A.

GNTA Quotes by TradingView
  • Ticker GNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,216,900
  • Market Cap $88.5M
  • Description
  • Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...
More about GNTA
Track This Portfolio

Track Algebris (Uk) LTD Portfolio

Follow Algebris (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algebris (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Algebris (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email